01 Dec 21

There can be no stone left unturned these days and so it becomes difficult not to “rabbit hole” oneself looking for threads stringing back to expected targets; so as to better inform our understanding of the COVID-19 enterprise fraud construct. We’ll rest our notions here on the idea that COVID was decades in the planning and we’ve evidenced it comprehensively and in ways no one else has.

Getting to brass tacks, the “rabbit holing” began by general inquiry with two specific search parameters: “project omicron” and “operation omicron.” I’m writing the article before I even get to “operation omicron.” The findings were that interesting with work still to do.

Let’s begin with the end of the search and work backwards.

We begin with old work for proper context and the source of the quote is Dr. David E. Martin/MCAM and it comes from Part I our three-part sub-series on Martin and his forensic patent examination work [emphasis added],

“Rather and very specifically, in 1999 as per a patent application filed 19 Apr 02, Anthony Fauci funded research at UNC Chapel Hill (Ralph Baric) specifically to create “an infectious replication defective coronavirus that was specifically targeted for human lung epithelium.” In other words, we made SARS and we patented it on 19 Apr 02 before any alleged Asian outbreak, which followed several months later.”

Dr. David E. Martin

We latch on to two critical vectors relative to COVID-19 and more specifically, SARS-CoV-2: genomic and gene sequencing work, which is well established and documented [you can’t patent something that is naturally occurring] and the funding, motive, intent, premeditation, planning, etc. to specifically leverage gain of function research to create a chimeric infectious replication defective coronavirus strain specifically targeting human lung epithelium.

Here, we latch on to published work right out of Anthony Fauci’s own NIH/NIAID that dates back to 15 Sep 15, entitled, ‘n-3 Fatty acids regulate the inflammatory-state related genes in the lung epithelial cells exposed to polycyclic aromatic hydrocarbons.’

The CDC defines polycyclic aromatic hydrocarbons as, “a class of chemicals that occur naturally in coal, crude oil, and gasoline. They also are produced when coal, oil, gas, wood, garbage, and tobacco are burned. PAHs generated from these sources can bind to or form small particles in the air. High-temperature cooking will form PAHs in meat and in other foods. Naphthalene is a PAH that is produced commercially in the United States to make other chemicals and mothballs. Cigarette smoke contains many PAHs.”

The study is characterized as, “Chronic airway inflammation is coordinated by a complex of inflammatory mediators, including eicosanoids. The aim of this study was to evaluate the impact of polycyclic aromatic hydrocarbons (PAHs) on the human lung epithelial carcinoma A549 cells supplemented with docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids.”

While the study doesn’t present as a “smoking gun” per se, it demonstrates that lung epithelium was the research vector and that non-vaccine treatments [supplementing with fatty acids] had demonstrated “anti-inflammatory” and “pro-resolving properties.” effects. It also allows us to latch onto the concept of “PAHs” being a constantly present trigger to aggravate lung epithelium and whereby a SARS-CoV-2 infection would target and therefore aggravate the same.

From the publication, we have to click on “Affiliations” at the top to expand the list and when we do, we latch on to, “Jagiellonian University, Medical College,” which attaches to 5 of the 7 contributors and we latch on to, “Department of Medicine, University of Connecticut Health Center, Farmington, CT, USA.”

Beginning with Farmington, here’s one study from 01 Aug 19 and only a few months before the outbreak. It was funded by NIH, “Scientists Discover Immune Cell Subtype in Mice That Drives Allergic Reactions.” The study did this, “Investigators at Yale University, New Haven, Connecticut, the Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, and their collaborators discovered a subtype of T cells—called T follicular helper cell 13, or Tfh13 cells—in laboratory mice bred to have a rare genetic immune disease called DOCK8 immunodeficiency syndrome. In humans, DOCK8 deficiency leads to recurrent viral infections of the skin and respiratory system and to severe allergies and asthma.”

Here’s a second and similar NIH study from 27 Jun 16 that overlaps Farmington and Jagiellonian.

Mice, T cells, rare, inflammatory response, genetic immune disease and Fauci. All direct overlaps and all related to SARS-CoV-2.

Here’s another study from 19 Mar 20 overlapping Farmington and another Fauci specialty – HIV – and recalling that SARS-CoV-2 has 6 artificial HIV inserts in it indicative of the GOF work that permits it to be patented.

The year leading up to the 31 Dec 19 first legacy report of COVID-19 to the U.S., Fauci’s NIAID funded Farmington at $6,855,981.

Turning our attention to Jagiellonian, we latch on to this report, ‘Final Report Summary – OMICRON (Opening doors to excellence. Enabling OMICs high-thROughput techNologies at the Faculty of Medicine Jagiellonian University Medical College)‘.

For context to the report, this is OMICRON.

Omicron is a closed project operational from 01 Jan 12 to 30 Jun 15. Hold on to that bit because it begins the raising of our questions. Omicron will continue on following its closing and we learn that in the final report linked above.

Note the project dates and description below.

Omicron describes itself as, “

Center for Medical Genomics OMICRON belongs to the Faculty of Medicine Jagiellonian University Medical College. It was created based on UE funded grant.

Center for Medical Genomics OMICRON specializes in high-throughput technologies in areas of genomics, transcriptomics and proteomics. We cooperate with other science centers worldwide.

Our mission is to excel in research on function of the genome, for the benefit of every human being. Our vision is to create the best team for genome research. Develop laboratory techniques and methods of data interpretation, in the spirit of scientific collaboration.

Omicron

Note the funding being granted by the European Union, “Jagiellonian University, the second oldest university in central Europe, is an important centre for scientific research. An EU-funded initiative worked to improve the research capacity of the Faculty of Medicine at the Jagiellonian University Medical College (JUMC) in Poland.”

Aside from its primary objective of being a “project…upgrading infrastructure as well as the training and development of researchers and future leaders,”

In the first phase, a modern omics centre, the Omicron Laboratory, was set up with state-of-the-art research equipment to support cutting-edge genomic, transcriptomic and proteomic research and analyses. Relevant training was provided for technicians and postdoctoral researchers.

SARS-CoV-2 is all about genetic sequencing and that’s Omicron’s specialty; that and sharing it with the world.

Pay particular attention to what follows [emphasis added],

Activities in the second project phase culminated in the hiring of 10 postdoctoral researchers, mostly Polish nationals, who brought scientific expertise from work at international research institutions in the EU and the United States. Seven qualified technical support staff were also recruited for technological and computational equipment support.

So, in essence, the European Union funded and established; in conjunction with the United States; within Jagiellonian University in Poland, an independent center specializing in genomic work and gene sequencing as aligned with worldwide sharing and collaboration initiatives and technologies.

Does that sound helpful in the context of today in light of everything else I’ve already evidenced?

Let’s examine some aspects of the Omicron final report beginning with the piece we said to hold onto; where the project ended but didn’t.

At the end of the project in May, 2015, the contracts of the employees were renewed for two additional years by the University in recognition of the success of the OMICRON Project and the strong accumulated know-how and expertise of the staff.

After the closing of the final phase of the project on May 15, 2015 the Omicron laboratory continues its activities. The Centre for Medical Genomics OMICRON is an independent unit of the Medical Faculty of the Jagiellonian University Medical College in Krakow, under the direct supervision of the Dean of the Medical Faculty. According to the statute of the Centre, the resources for functioning of the Centre are provided by the statutory funds of the Jagiellonian University Medical College by the decision of the Dean. Current support for the Centre, provided by the Dean of the Medical Faculty, is 450,000 PLN, covering expenses since the completion of the Omicron Project on May 15th until the end of Year 2015. This includes 305,000 PLN in the form of the salaries of the staff of the Centre and 145,000 PLN for the material expenses. All projects executed in the Omicron Centre have to provide financial resources for their relevant expenses (e.g. reagents, consumables, indirect costs).
The majority of the postdoctoral researchers and laboratory technicians, hired for the project are now employed at the laboratory.

Omicron is funded under the European Commission’s REGPOT initiative, which is funded at $340 million – “RESEARCH POTENTIAL OF CONVERGENCE REGIONS.” It’s described as,

Europe needs to exploit its research potential, particularly in the less advanced regions that are remotely situated from the European core of research and industrial development. A strategy of inclusiveness can potentially benefit the social fabric as well as the research community and the industry, locally and at the level of the European Research Area.

That bears a striking similarity to two pervasive themes in all of this – global governance and Obama’s expansion of Medicaid as a mechanism to expand the database of CMS data to drive the COVID enterprise fraud scheme that entails stealing infection and mortality data from comorbidities and fraudulently propagating them as “COVID.” I wrote ONE TWO articles on it and a THIRD underpinning it all with the ACA/Obamacare.

This is why I think I’m correct here.

To fully realise the European Research Area in the enlarged Union, all regions must take part and must be supported if necessary. This strategy directly benefits SMEs and industrial
organisations in the convergence regions.

View that from the lens of capturing a data base from which to steal for data propagation. It is exactly what Obama did with the expansion of Medicaid and like always, it ties to funding.

Strong synergies will be sought with the Community regional policy. Actions under this heading will identify needs and opportunities for reinforcing the research capacities of emerging and existing centres of excellence in convergence regions which may be met by Structural and
Cohesion funds.

Synergies will also be sought with the Competitiveness and Innovation programme in order topromote the regional commercialisation of research and development in collaboration with
industry.

That’s Eurotrash for the same bureaucratic bullshit that is all of the same “community outreach” and the institution of federalism being bent back against the people. It’s globalism that directly translates to the existing and evidenced American Obama version.

Is this the European Union’s equivalent to what America did to position itself with the requisite infrastructure and reach to be able to drive a fraudulent pandemic of cooked-up data? It sure looks like it. It’s looking like Omicron was positioned to contribute to the genetics, genetic sequencing and the ability to effectively communicate it to the entire world.

The SARS-CoV-2 gene sequence was distributed to recipients by a short telephone call [Martin/MCAM.] Think about that for a second relative to what I just outlined.

To summarize, Omicron, is a program and laboratory established as an independent center within a university that specializes in genetics and sharing that information worldwide; and it was funded by the EU within a broader initiative that functions exactly like the expansion of Medicaid in the U.S. as data reservoir for the COVID-19 pandemic.

From the final report and through the lens of fraud, if Omicron were implicated, this could serve as the financial incentive along with a brand new state-of-the art laboratory,

The new generation of scientists trained at JUMC Faculty of Medicine will continuously boost the establishment of biotech companies and high-tech enterprises in the region. Creation of such competitive and advanced centre with international collaborations is likely to generate potential for future spin-off and spin-out companies and developments on the border of science and R&D.

Here’s what the EU funded Omicron brought to Jagiellonian,

The underground floor includes:
1) Room for biorepository (biobanking), circa 53 m2;
2) Computer server room, circa 24 m2;
3) Social room with lavatories, circa 58 m2;
4) Conference room, circa 32 m2;
5) Office space, circa 26 m2;
6) Room for proteomics team (4 people), circa 21 m2;
7) Laboratory technicians’ room (4 people), circa 28 m2;
8) Postdoctoral fellows room (6 people), circa 25 m2;
9) Director’s room, circa 20 m2;
In addition underground floor contains communication corridors.

Ground floor is divided into three modules:
1) Pre-analytical module contains three rooms: nucleic acid isolation circa 17 m2, cell culture circa 12 m2, PCR setup and sequencing library preparation circa 21 m2, corridor circa 12 m2; altogether circa 62 m2;
2) Proteomics module contains one room with corridor, circa 31 m2;
3) Sequencing module contains one room with corridor, circa 69 m2;
The laboratory space on the ground floor is about 162 m2.

Specification of OMICRON Laboratory Equipment:

1. Mass spectrometer
2. Equipment for nucleic acid electrophoresis and 2-dimensional protein electrophoresis with
   imaging capabilities
3. Real-time thermocyclers (384 wells and 48 wells) and gradient thermocycler (96 well)
4. Microarray scanner (HiScan) with auxillary equipment and a next generation sequencer (MiSeq)
5. Ultra-low temperature freezer, liquid nitrogen storage tank, liquid nitrogen transport tank, cell
   culture incubator
6. Ultrapure water maker
7. Centrifuges and a vacuum concentrator
8. Nucleic acid ultrasonic fragmenter
9. High-performance liquid chromatographer
10. Automated workstations for pre-PCR tasks and for post PCR tasks, nucleic acid quality and quantity
    analyzer
11. Automated biorobot for nucleic acid isolation
12. 12 laptop computers
13. Next generation sequencer (GS Junior)
14. Instrument for separation of DNA fragments of desired length
15. Small and medium laboratory equipment (e.g. pipets, scales, pH-meter etc.) in 9 parts
16. Craddle shaker (2 pieces)
17. Western blot instrument
18. 96-well head for the real-time PCR thermocycler
19. Microcentrifuges and minicentrifuges
20. UV/VIS spectrophotometer
21. Small cell culture incubator
22. Absorbance filters 490 and 660 nm
23. High-throughput tissue homogenizer
24. Additional rotators for the centrifuges
25. High-speed centrifuge
26. Pipets
27. Soft tissue homogenizer
28. Stereotactic table
29. 96-well plate shaker
30. Fluorescence microscope
31. Orbital shaker

Remember, they never have to tell you everything. That’s why it’s called fraud. So, all that and opportunities for spin-offs. Maybe those aren’t kickbacks, maybe they are. This will require much more digging out. I haven’t even look at the other half of the original research parameters so don’t forget that!

Here’s another reason I think I may be correct and we’ll end with it.

Finally, we latch onto Oxford.

If all of these circumstances are just circumstances and I’m “rabbit holing” to no good end, how do we explain the next piece out of the final report.

The following European institutions agreed to collaborate with the Faculty of Medicine in the framework of the OMICRON Project:

1. University of Oxford, UK (Biomedical Research Centre, Department of Metabolic Diseases, Department of Cardiovascular Medicine)
2. King’s College, University of London, UK
3. University of Wuerzburg, Department of Cardiology, Germany
4. Norwegian University of Science and Technology (NTNU), Trondheim, Norway
5. Department of Biology, Faculty of Medicine, Masaryk University, Brno, the Czech Republic
6. deCODE, Reykijavik, Iceland
7. Institute of Human Genetics, International Centre for Life Newcastle, UK.
8. Technical University in Dresden, Medical Clinic III, Genetics and Prevention of Diabetes, Germany
9. Institute of Molecular Biology and Biotechnology, Heraklion, Greece
10. Hannover Medical School, Germany
11. University of Glasgow, College of Medical, Veterinary and Life Science (MVLS)

Representatives of all above-mentioned organs were invited to meeting, conference and were asked about advises and support to the OMICRON project. They are to assess the progress made within the project implementation, as well as to monitor its impact and objectives achieved.

It’s number one that obviously and mostly has our attention – Oxford.

We keep finding the same people swimming in the same pools no matter which pool we look in or which country that pool is located. Circumstances, I’m sure.

Why did they move so quickly to replace “Nu” with “Omicron” and why does this Omicron fit into the other Omicron’s context so well? That context being COVID-19. And why does it fit precisely within a broader construct that appears to be the direct analog to Obama’s expansion of Medicaid as a function of the fraudulent pandemic?

What if things like “Delta” and “Omicron” are not only “variants” but monikers for past staging operations needed to build the fraud infrastructure and which now coincide in terms of their the roll-out on the established timeline? A thought and a loose one at that.

Like with everything else, I suppose it’s all just coincidence. That and circumstances.

The fact that today tens of research projects are being run or are being carried out, financed by national and European institutions, is best evidence of the importance of this infrastructure investment. The opening of the laboratory would not be possible without the participation of young researchers employed and trained thanks to Omicron funds. One cannot forget about the role of the international exchange organized as part of the project. The visits of over 36 professors from leading European, American, Canadian and Australian centers contributed to the improvement of the competences of researchers from the Jagiellonian University and other academic centers in Krakow. They also constituted excellent promotion of the university, city and country among internationally renowned research authorities. The participation of about 150 JU researchers in trainings, workshops and international scientific conferences is an investment in the future of the university.

The work on this will continue but it was worthy of sharing now.

-End-